Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license

Sensitive

Aminoglycoside-induced hearing loss (m.1555A>G)

MT-RNR1 · rs267606617

Strength of the evidence

4 / 4

ClinVar classifies it as disease-causing (or likely), reviewed at 3 of 4 stars.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What ClinVar records

Classification Pathogenic; drug response for Aminoglycoside-induced deafness, Mitochondrial non-syndromic sensorineural hearing loss, Restrictive cardiomyopathy, Gentamicin response, Rare genetic deafness and 11 more; reviewed by expert panel (3 of 4 stars, 20 submitters), last evaluated 2022-12-15. ClinVar record 9628 NC_012920.1(MT-RNR1):m.1555A>G

Change history MyGeneLog™ keeps a copy of every weekly release from 2026-10-19 and compares them. This position's classification has not changed since.

What this is ClinVar's aggregate record for this position (as of its 2026-11-16 release), not a result about you. A classification describes the variant against the condition named, as laboratories submitted it. Whether a person carries this variant, and what that would mean for them, is a question for a clinical test and a genetic counsellor.

How common each version is

AG
Korean KRGDB
A 99.9% · G 0.1%
Japanese ToMMo
A 99.9% · G 0.1%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study.

What each result means

A The reference base. Mitochondrial DNA is present in many copies per cell and is reported as a single letter rather than a pair, because it is not inherited in two copies the way chromosomal DNA is.
G The m.1555A>G variant. It predisposes to hearing loss after aminoglycoside antibiotics, and the loss can follow a single standard dose at a normal blood level. It is inherited from the mother and passes to all of her children; a father passes it to none.
If this variant is present, aminoglycosides should be avoided unless there is no effective alternative and the infection is life-threatening — a decision for the treating team, not one to make in advance. The hearing loss is permanent, which is why the guideline exists.
Source

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Aminoglycoside-induced hearing loss (m.1555A>G) (rs267606617). MyGeneLog™. https://www.mygenelog.com/variants/rs267606617

← See all variants